ALPMY
Astellas Pharma Inc Unsponsored ADR (ALPMY) [ST]
▲ 3.45%
prev close
ASTELLAS PHARMA UNSP/ADR
Congressional Trades
1
All tracked trades
Members Trading
1
Unique members
Net Activity
+1
1 buys · 0 sells
Members Who Traded This Stock
1 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2023-02-27 | ALPMYAstellas Pharma Inc Unsponsored ADR | Buy | $15,001 - $50,000 | 1109d ago | — |
2023-02-27
Daniel Goldman
ALPMY
Amount
$15,001 - $50,000
Filed
1109d ago
Recent News
Powered by Polygon.io
4D Path Joins Phase II Clinical Trial to Advance Predictive Biomarkers in Bladder Cancer
Geographic Atrophy Market to Surge Significantly During the Forecast Period (2025–2034) Due to Rising Adoption of Complement Inhibitor Therapies | DelveInsight
CytomX Therapeutics to Present at the Jefferies London Healthcare Conference
Sutro Biopharma Highlights Next-Generation ADC Innovation at Virtual R&D Day
CytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025
Trade Timeline
Congressional activity, newest first
Daniel Goldman
2023-02-27 · Purchase
$15,001 - $50,000